NO20054776L - Kontrollert frigivelsessystem som inneholder sakkaroseacctatisobutyrat - Google Patents
Kontrollert frigivelsessystem som inneholder sakkaroseacctatisobutyratInfo
- Publication number
- NO20054776L NO20054776L NO20054776A NO20054776A NO20054776L NO 20054776 L NO20054776 L NO 20054776L NO 20054776 A NO20054776 A NO 20054776A NO 20054776 A NO20054776 A NO 20054776A NO 20054776 L NO20054776 L NO 20054776L
- Authority
- NO
- Norway
- Prior art keywords
- controlled release
- system containing
- octatisobutyrate
- containing sucrose
- release system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Foreliggende oppfinnelse angår et system for konttoUert fiigivelse av farmasøytisk aktive substanser, nevnte system inneholder sakkaroseacetatisobutyrat (SAIB) og et annet løsemiddel.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10312346A DE10312346A1 (de) | 2003-03-20 | 2003-03-20 | Kontrolliertes Freisetzungssystem |
PCT/EP2004/002318 WO2004082658A1 (de) | 2003-03-20 | 2004-03-06 | Kontrolliertes freisetzungssystem enthaltend saccharoseacetatisobutyrat |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20054776L true NO20054776L (no) | 2005-10-17 |
Family
ID=32920993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20054776A NO20054776L (no) | 2003-03-20 | 2005-10-17 | Kontrollert frigivelsessystem som inneholder sakkaroseacctatisobutyrat |
Country Status (18)
Country | Link |
---|---|
US (1) | US8231903B2 (no) |
EP (1) | EP1608335B1 (no) |
JP (1) | JP4863867B2 (no) |
AR (1) | AR043423A1 (no) |
AT (1) | ATE380017T1 (no) |
AU (1) | AU2004222646B2 (no) |
BR (1) | BRPI0408555A (no) |
CA (1) | CA2519351C (no) |
CL (1) | CL2004000566A1 (no) |
DE (2) | DE10312346A1 (no) |
ES (1) | ES2297396T3 (no) |
GT (1) | GT200400045A (no) |
MX (1) | MXPA05009910A (no) |
NO (1) | NO20054776L (no) |
NZ (1) | NZ542477A (no) |
PE (1) | PE20041024A1 (no) |
TW (1) | TW200505488A (no) |
WO (1) | WO2004082658A1 (no) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040001889A1 (en) | 2002-06-25 | 2004-01-01 | Guohua Chen | Short duration depot formulations |
AU2003299659A1 (en) | 2002-12-13 | 2004-07-09 | Durect Corporation | Oral drug delivery system comprising high viscosity liquid carrier materials |
NZ553369A (en) * | 2004-09-17 | 2010-11-26 | Durect Corp | Sustained local anesthetic composition containing preferably a sugar ester such as saib |
US20070027105A1 (en) | 2005-07-26 | 2007-02-01 | Alza Corporation | Peroxide removal from drug delivery vehicle |
DE102006010643A1 (de) * | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
DE102006049520A1 (de) | 2006-10-20 | 2008-04-24 | Bayer Healthcare Ag | Verfahren zur Herstellung von Pradofloxacin |
PL2117521T3 (pl) | 2006-11-03 | 2012-11-30 | Durect Corp | Transdermalne systemy dostarczania zawierające bupiwakainę |
WO2008143992A2 (en) * | 2007-05-18 | 2008-11-27 | Durect Corporation | Improved depot formulations |
EP2219622A1 (en) | 2007-12-06 | 2010-08-25 | Durect Corporation | Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition |
WO2009100222A1 (en) * | 2008-02-08 | 2009-08-13 | Qps Llc | Non-polymeric compositions for controlled drug delivery |
US7923447B2 (en) * | 2008-03-17 | 2011-04-12 | Academic Pharmaceuticals Incorporated | Parenteral solutions containing metolazone |
WO2009145674A1 (ru) * | 2008-05-28 | 2009-12-03 | Учреждение Российской Академии Наук Институт Биохимической Физики Им. Н.М. Эмануэля Ран (Ибхф Ран) | Средство для повышения октанового числа бензинового автомобильного топлива |
US20100260844A1 (en) | 2008-11-03 | 2010-10-14 | Scicinski Jan J | Oral pharmaceutical dosage forms |
CN102764257B (zh) * | 2011-10-21 | 2013-09-25 | 四川百利药业有限责任公司 | 一种马来酸氟吡汀缓释片剂 |
US9572885B2 (en) | 2013-03-15 | 2017-02-21 | Durect Corporation | Compositions with a rheological modifier to reduce dissolution variability |
CN103550148A (zh) * | 2013-10-30 | 2014-02-05 | 游锡火 | 延胡索酸泰妙菌素长效注射剂制备方法 |
CN103550149A (zh) * | 2013-10-30 | 2014-02-05 | 游锡火 | 含抗寄生虫药物长效注射剂的制备技术 |
CN103536531A (zh) * | 2013-10-30 | 2014-01-29 | 王玉万 | 甲磺酸达氟沙星长效注射剂制备方法 |
CN103520098A (zh) * | 2013-10-30 | 2014-01-22 | 王玉万 | 恩诺沙星兽用长效注射剂的制备方法 |
CN103520168A (zh) * | 2013-10-30 | 2014-01-22 | 游锡火 | 含延胡索酸泰妙菌素的复方注射剂 |
CN103550150B (zh) * | 2013-10-30 | 2016-06-08 | 北京中农华威制药有限公司 | 改进的含二甲基硅油的注射剂 |
CN103520099A (zh) * | 2013-10-30 | 2014-01-22 | 王玉万 | 含有效成份为沃尼妙林的长效注射剂 |
CN103520167A (zh) * | 2013-10-30 | 2014-01-22 | 游锡火 | 含硫酸头孢喹诺和甲磺酸达氟沙星的长效注射剂 |
ES2956316T3 (es) | 2018-04-25 | 2023-12-19 | Elanco Animal Health Gmbh | Proceso para la hidrólisis de ésteres carboxílicos de quinolona |
CA3167217A1 (en) | 2020-01-13 | 2021-07-22 | Durect Corporation | Sustained release drug delivery systems with reduced impurities and related methods |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5746986A (en) * | 1980-09-02 | 1982-03-17 | Dai Ichi Seiyaku Co Ltd | Pyrido(1,2,3-de)(1,4)benzoxazine derivative |
US4670444B1 (en) * | 1980-09-03 | 1999-02-09 | Bayer Ag | and-naphthyridine-3-carboxylic acids and antibacte7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-quinoline-rial agents containing these compounds |
US4472405A (en) * | 1982-11-12 | 1984-09-18 | Riker Laboratories, Inc. | Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives |
US4730000A (en) * | 1984-04-09 | 1988-03-08 | Abbott Laboratories | Quinoline antibacterial compounds |
AT392789B (de) * | 1985-01-23 | 1991-06-10 | Toyama Chemical Co Ltd | Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten |
IN166416B (no) * | 1985-09-18 | 1990-05-05 | Pfizer | |
DE4319649A1 (de) * | 1993-03-18 | 1994-09-22 | Asta Medica Ag | Feste Flupirtin enthaltende orale Darreichungsformen mit kontrollierter Wirkstoffabgabe |
PT754032E (pt) * | 1994-04-08 | 2002-05-31 | Atrix Lab Inc | Composicoes liquidas para difusao |
DE4416927C1 (de) * | 1994-05-13 | 1995-08-31 | Lohmann Therapie Syst Lts | Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung |
US6413536B1 (en) * | 1995-06-07 | 2002-07-02 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system and medical or surgical device |
US5968542A (en) * | 1995-06-07 | 1999-10-19 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system as a device |
US5747058A (en) * | 1995-06-07 | 1998-05-05 | Southern Biosystems, Inc. | High viscosity liquid controlled delivery system |
US5736152A (en) * | 1995-10-27 | 1998-04-07 | Atrix Laboratories, Inc. | Non-polymeric sustained release delivery system |
RU2173318C2 (ru) * | 1996-02-23 | 2001-09-10 | Байер Акциенгезелльшафт | 8-циан-1-циклопропил-7-(2,8-диазабицикло(4.3.0)-нонан-8-ил)-6-фтор-1,4-дигидро-4-оксо-3-хинолинкарбоновые кислоты, их производные и фармацевтическая композиция, обладающая антибактериальной активностью |
US6391336B1 (en) * | 1997-09-22 | 2002-05-21 | Royer Biomedical, Inc. | Inorganic-polymer complexes for the controlled release of compounds including medicinals |
US7128927B1 (en) * | 1998-04-14 | 2006-10-31 | Qlt Usa, Inc. | Emulsions for in-situ delivery systems |
JP2003501375A (ja) * | 1999-06-04 | 2003-01-14 | アルザ・コーポレーション | 移植可能なゲル組成物および製造方法 |
KR20020040767A (ko) | 1999-08-03 | 2002-05-30 | 아베데 파르마 게엠베하 운트 콤파니 카게 | 개와 고양이에서 퇴행성 관절 질환으로 인한 통증을경감시키기 위한 플루피르틴의 용도 |
DK1274459T3 (da) * | 2000-04-19 | 2006-02-06 | Genentech Inc | Præparater med vedholdende frigivelse indeholdende væksthormon |
US7318931B2 (en) * | 2001-06-21 | 2008-01-15 | Genentech, Inc. | Sustained release formulation |
US20050031650A1 (en) * | 2002-08-26 | 2005-02-10 | Ethypharm | Composition with gelling properties for the sustained delivery of bioactive substances |
DE10242088A1 (de) * | 2002-09-11 | 2004-03-25 | Bayer Ag | Kontrolliertes Freisetzungssystem, welches Saccharoseacetatisobutyrat enthält |
-
2003
- 2003-03-20 DE DE10312346A patent/DE10312346A1/de not_active Withdrawn
-
2004
- 2004-02-27 AR ARP040100625A patent/AR043423A1/es not_active Application Discontinuation
- 2004-03-06 WO PCT/EP2004/002318 patent/WO2004082658A1/de active IP Right Grant
- 2004-03-06 JP JP2006504570A patent/JP4863867B2/ja not_active Expired - Fee Related
- 2004-03-06 NZ NZ542477A patent/NZ542477A/en not_active IP Right Cessation
- 2004-03-06 ES ES04718201T patent/ES2297396T3/es not_active Expired - Lifetime
- 2004-03-06 CA CA2519351A patent/CA2519351C/en not_active Expired - Fee Related
- 2004-03-06 DE DE502004005652T patent/DE502004005652D1/de not_active Expired - Lifetime
- 2004-03-06 MX MXPA05009910A patent/MXPA05009910A/es active IP Right Grant
- 2004-03-06 BR BRPI0408555-8A patent/BRPI0408555A/pt not_active Application Discontinuation
- 2004-03-06 AT AT04718201T patent/ATE380017T1/de not_active IP Right Cessation
- 2004-03-06 AU AU2004222646A patent/AU2004222646B2/en not_active Ceased
- 2004-03-06 EP EP04718201A patent/EP1608335B1/de not_active Expired - Lifetime
- 2004-03-18 CL CL200400566A patent/CL2004000566A1/es unknown
- 2004-03-18 GT GT200400045A patent/GT200400045A/es unknown
- 2004-03-19 PE PE2004000292A patent/PE20041024A1/es not_active Application Discontinuation
- 2004-03-19 TW TW093107363A patent/TW200505488A/zh unknown
-
2005
- 2005-09-12 US US11/243,293 patent/US8231903B2/en active Active
- 2005-10-17 NO NO20054776A patent/NO20054776L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1608335A1 (de) | 2005-12-28 |
AR043423A1 (es) | 2005-07-27 |
US20060034926A1 (en) | 2006-02-16 |
ES2297396T3 (es) | 2008-05-01 |
CA2519351C (en) | 2012-02-07 |
CL2004000566A1 (es) | 2005-02-04 |
DE502004005652D1 (de) | 2008-01-17 |
CA2519351A1 (en) | 2004-09-30 |
US20090246277A9 (en) | 2009-10-01 |
AU2004222646B2 (en) | 2010-04-29 |
TW200505488A (en) | 2005-02-16 |
GT200400045A (es) | 2004-10-21 |
PE20041024A1 (es) | 2005-01-27 |
AU2004222646A1 (en) | 2004-09-30 |
BRPI0408555A (pt) | 2006-03-21 |
MXPA05009910A (es) | 2005-11-04 |
DE10312346A1 (de) | 2004-09-30 |
EP1608335B1 (de) | 2007-12-05 |
WO2004082658A1 (de) | 2004-09-30 |
ATE380017T1 (de) | 2007-12-15 |
US8231903B2 (en) | 2012-07-31 |
JP4863867B2 (ja) | 2012-01-25 |
NZ542477A (en) | 2009-02-28 |
JP2006520346A (ja) | 2006-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054776L (no) | Kontrollert frigivelsessystem som inneholder sakkaroseacctatisobutyrat | |
NO20065052L (no) | Krystallinsk polymorf av et bazedoksifenacetat | |
NO20062709L (no) | Stamceller som er egnet for transplantasjon, fremstilling derav og farmasoytiske preperater omfattende nevnte stamceller | |
DK1206467T3 (da) | N-heterocykliske derivater som NOS-inhibitorer | |
EA200800415A1 (ru) | Удаление пероксида из носителя для доставки лекарственного средства | |
NL300343I1 (nl) | 6-alfa, 9-alfa-difluor-17-alfa-(2-furanylcarboxyl)oxy-11-beta-hydroxy-16-alfa-methyl-3-oxo-androst-1, 4-dieen-17-carbothionzuur-s-fluormethylester alseen ontstekingremmend middel | |
DK1299348T3 (da) | Forbindelser og sammensætninger til levering af aktive midler | |
DK1032374T3 (da) | Sphroider, fremgangsmåde og farmaceutiske præparater | |
ATE485835T1 (de) | Antikörper enthaltende pharmazeutische lösungen | |
DK1526134T3 (da) | Triazolyltropanderivater som CCR5-modulatorer | |
NO20066055L (no) | Pyridinderivater | |
NO20030381D0 (no) | Bicyklopyrazoler som er aktive som kinaseinhibitorer, fremgangsmåte for deres fremstilling og farmasöytiske preparater som inneholder slikeforbindelser | |
NO20080505L (no) | Ionisk vaeske rekonstituerte cellulosekompositter som faste baerematriser | |
DK1863812T3 (da) | Dipeptidylpeptidase-IV-inhiberende forbindelser, fremgangsmåder til fremstilling af de samme og farmaceutiske sammensætninger indeholdende de samme som aktive midler | |
NO20060631L (no) | Fast dispersjon av takrolimus | |
NO20053663L (no) | Transdermal granistetron | |
IS2170B (is) | Sýklópentanóindól, efnablöndur sem innihalda slíkefnasambönd og meðhöndlunaraðferðir | |
DK0915898T3 (da) | Krystalform I af clarithromycin | |
NO20081160L (no) | Benzimidazoltiofen forbindelser | |
ATE472529T1 (de) | Prolinamidderivate als natriumkanalmodulatoren | |
NO20065319L (no) | Piperidinderivater som modulatorer for kjemokinreseptor CCR5 | |
IS8051A (is) | Kladríbínefnablöndur til inngjafar um munn | |
NO20055631L (no) | Doseringsform inneholdende pantoprazol som aktiv ingrediens | |
NO20070570L (no) | Forbindelser. | |
ATE485261T1 (de) | Salicylsäurederivate |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |